Ergoteles LLC Axonics, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $1.65 Million - $2.69 Million	41,725 Added 290.54%	56,086 $3.18 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $462,025 - $662,933	10,563 Added 278.12%	14,361 $899,000
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $189,937 - $278,583	3,798 New	3,798 $213,000
Q1 2021 May 12, 2021	SELL	$49.14 - $59.89 $889,434 - $1.08 Million	-18,100 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$42.19 - $51.5 $763,639 - $932,150	18,100 New	18,100 $904,000

188

41.3M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.